Search results
New 'FLiRT' COVID-19 Variants Are Responsible For 25% Of Infections
Women's Health via Yahoo News· 3 days agoStaying up to date with your booster shots can provide some protection against this new variant,...
Injectables Trends From Around the World
Allure via Yahoo News· 2 days agoUntil then, companies in the United States are working on making their own skin boosters. For example, Juvéderm’s skin booster, Skinvive, was granted < ...
FDA clears Outset Medical's new dialysis system accessory By Investing.com
Investing.com· 5 days agoOutset Medical, Inc. (NASDAQ:OM), a company focused on innovative medical technology, has received...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 5 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
DTC brand Daily Harvest adds Target to growing list of retailers
Axios· 5 days agoDaily Harvest's products are now available for sale at nearly 26,000 retail distribution points with...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
'Low' risk and tests for all? Botched COVID response hangs over feds' bird-flu plans
Just the News· 3 days agoA shadowy virus is spreading with unknown frequency and risk to humans. The Centers for Disease...
Health Freedom Prevails Against the CDC and NIH
Mercola· 6 days agoIn the video above, Del Bigtree, founder of “The Highwire” and the Informed Consent Action Network (icandecide.org), shares some of the recent lawsuits ICAN has won against the National Institutes ...
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Lodi News-Sentinel· 4 days agoFirst quarter 2024 total revenue of $29.5 million, which includes TAVALISSE® net product sales of $21.1 million and REZLIDHIA® net product sales of $4.9 millionExpanded Rigel's portfolio with acquisition of